Pura Vida Investments’s Adaptive Biotechnologies ADPT Stock Holding History

Pura Vida Investments’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-177,700	Closed	-$1.19M	–	84
2023 Q2	$1.19M	Buy	+177,700	New	+$1.32M	0.16%	73
2023 Q1	–	Sell	-750,000	Closed	-$5.73M	–	76
2022 Q4	$5.73M	Buy	+750,000	New	+$5.84M	0.3%	82
2022 Q1	–	Sell	-161,800	Closed	-$4.54M	–	229
2021 Q4	$4.54M	Buy	161,800 +121,800	+305%	+$3.73M	0.16%	119
2021 Q3	$1.36M	Buy	+40,000	New	+$1.45M	0.04%	206

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Pura Vida Investments's ADPT Position: Q3 2023 in Review

Pura Vida Investments sold out of Adaptive Biotechnologies (ADPT) in Q3 2023, closing a stake of 155,059 shares — an estimated $1.04M sold.

Pura Vida Investments first reported a position in ADPT in Q2 2019 and held it in 12 quarters. The position peaked at $17.7M in Q4 2020. 190 funds tracked by Wall St. Rank hold ADPT as of Q3 2023.

Pura Vida Investments reported no remaining Adaptive Biotechnologies position as of Q3 2023 after selling out during the quarter.
Pura Vida Investments sold 155,059 Adaptive Biotechnologies shares in Q3 2023, an estimated $1.04M.
Pura Vida Investments first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 12 quarters.
Pura Vida Investments's Adaptive Biotechnologies position peaked at $17.7M in Q4 2020.
190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2023.

Based on Pura Vida Investments's 13F filing for Q3 2023, filed 14 Nov 2023.